Paediatric Respiratory Reviews
Volume 7, Issue 1 , Pages 60-66 , March 2006

Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead

References 

  1. Hilliard T, Chambers T. The relationship between paediatricians and commerce. Paediatr Respir Rev. 2006;7:54–59
  2. House of Commons Health Select Committee. The Influence of the Pharmaceutical Industry. Fourth Report Session 2004–5. London: The Stationary Office Limited. http://www.parliament.the-stationery-office.co.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf.
  3. Katz D, Caplan AL, Merz JF. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioethics. 2003;3:39–46
  4. Roughead EE, Gilbert AL, Harvey KJ. Self regulatory codes of conduct: are they effective in controlling pharmaceutical representatives to general medical practitioners. Int J Health Serv. 1998;28:269–279
  5. Association of the British Pharmaceutical Industry. ABPI Code of Practice for the Pharmaceutical Industry. 2003. Whitehall, London: Prescription Medicines Code of Practice Authority. http://www.abpi.org.uk/%2Fpublications%2Fpdfs%2Fcodeofpractice2003.pdf.
  6. Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom. http://www.fpm.org.uk/.
  7. The General Medical Council. http://www.gmc-uk.org/.
  8. Smith R, Abbassi K. No more free lunches. BMJ. 2003;326:1155–1156
  9. Collier J. The pharmaceutical industry as an informant. Lancet. 2002;360:1405–1409
  10. Ferner RE. The influence of big pharma. BMJ. 2005;330:855–856
  11. Barnett A. Revealed: how drug firms ’hoodwink’ medical journals. The Observer 7 December 2003. http://observer.guardian.co.uk/uk_news/story/0,1101680,00.html.
  12. Boseley S. ’It said the drug was the best thing since sliced bread. I don’t think it is’. The Guardian 7 February 2002. http://www.guardian.co.uk/uk_news/story/0,646061,00.html.
  13. No Free Lunch. http://www.nofreelunch.org/.
  14. Wager E. How to dance with porcupines: rules and guidelines on doctor's relations with drug companies. BMJ. 2003;326:1196–1198
  15. Beck U. Risk Society towards Modernity. London: Sage; 1992;
  16. The Association of the British Pharmaceutical Industry Press Release. Website Link to Clinical Trial Register Set Up. http://www.abpi.org.uk/press/press_releases_05/050701.asp.
  17. Parliamentary Office of Science and Technology. Handling Uncertainty in Scientific Advice. June 2004. Number 220. http://www.parliament.uk/documents/upload/POSTpn220.pdf.
  18. Parliamentary Office of Science and Technology. Vaccines and Public Health. June 2004. Number 219. http://www.parliament.uk/documents/upload/POSTpn219.pdf.
  19. Bosely S. UK Drug Firms Accused of Failing NHS. 15 December 2003. http://www.guardian.co.uk/uk_news/story/0,1107032,00.html.
  20. Murray R. Drugs Firms are Scaring People for Profit. 12 November 2004. London: Telegraph Group Limited. http://www.telegraph.co.uk/news/main.jhtml?xml=/news/2004/11/12/ndrug12.xml.
  21. Turk G, Moroni G, Pampuro S. Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure. Int J Antimicrob Agents. 2002;20:282–288
  22. GlaxoSmithKline. Data on File HIVDOF042.
  23. GlaxoSmithKline. Data on File HIVDOF042.
  24. Association of the British Pharmaceutical Industry. ABPI Response to Health Select Committee Enquiry into the Influence of the Pharmaceutical Industry. Meeting NHS Needs 2.8. 16 August 2004. Whitehall, London: The Association of the British Pharmaceutical Industry. http://www.abpi.org.uk/information/industry_positions/hsc_submission_aug16.doc.
  25. Horton R. The less acceptable face of bias. Lancet. 2000;356:959–960
  26. Association of the British Pharmaceutical Industry. Press Release. Consultation is at Heart of Review of Pharmaceutical Industry Code of Practice. 17 December 2004. Whitehall, London: The Association of the British Pharmaceutical Industry. http://www.abpi.org.uk/press/press_releases_04/041217.asp.
  27. Association of the British Pharmaceutical Industry Press Release 5 May 2005. http://www.abpi.org.uk/press/press_releases_05/050505.asp Code of Review Attracts Strong Response. Whitehall, London: The Association of the British Pharmaceutical Industry.
  28. Association of the British Pharmaceutical Industry. How the Pharmaceutical Industry and the NHS can Work Together. 22 July 2005. http://www.abpi.org.uk/press/press_releases_05/050722.asp.
  29. Joint Declaration of CPME and EFPIA on the Cooperation between the Medical Profession and the Pharmaceutical Industry. 8 June 2005. Brussels, Belgium: EFPIA. http://www.efpia.org/3_press/20050608.htm.
  30. The Blue Guide MHRA. Advertising and Promotion of Medicines in the UK. London: MHRA, 2005.
  31. Prescription Medicines Code of Practice Authority 2004. Code of Practice Review Numbers 43, 44, 45 and 46. Whitehall, London: Prescription Medicines Code of Practice Authority.
  32. Royal College of Paediatrics and Child Health. Good Medical Practice in Paediatrics and Child Health. Duties and Responsibilities of Paediatricians. London: Royal College of Paediatrics and Child Health. http://www.rcpch.ac.uk/publications/recent_publications/Support.pdf.
  33. NHS and Pharmaceutical Industry Working Together for Patients. ABPI and NHS Alliance. Whitehall, London: The Association of the British Pharmaceutical Industry and the NHS Alliance.
  34. Pfizer. http://www.pfizer.co.uk/template3.asp?pageid=46.
  35. GSK. http://gsk.com/corporate_responsibility/cr_issues/business_ethics.htm.
  36. Astra Zeneca. http://www.astrazeneca.com/article/511606.aspx.
  37. Wyeth. http://www.wyeth.com/about/mission.asp.
  38. Johnson and Johnson. http://www.jnj.com/our_company/our_credo/index.htm.
  39. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA. 2000;283:373–380
  40. Komesaroff PA, Kerridge IH. Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. Med J Aust. 2004;176:118–121
  41. The Association of the British Pharmaceutical Industry. Facts and Statistics from the Pharmaceutical Industry. Whitehall, London: The Association of the British Pharmaceutical Industry. http://www.abpi.org.uk/statistics/intro.asp.
  42. Shaw G. Drug Discovery and Development. Boston, MA: Bain and Company, 2004. http://www.bain.com/bainweb/LocalOffices/in_the_news_detail.asp?office_id=106&language=1&menu_id=127&id=18154&menu_url=office%5Fpublications%2Easp.
  43. MHRA. Who we are. http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=21.
  44. POST homepage. http://www.parliament.uk/parliamentary_offices/post.cfm.

 The views expressed in this paper are those of the authors and not necessarily those of GlaxoSmithKline UK Ltd.

PII: S1526-0542(05)00117-X

doi: 10.1016/j.prrv.2005.11.002

Paediatric Respiratory Reviews
Volume 7, Issue 1 , Pages 60-66 , March 2006